Nutra Pharma Corp (NPHC) Change in Account Payables (2012 - 2026)

Nutra Pharma has disclosed Change in Account Payables across 15 years of filings, most recently posting $44766.0 for Q2 2026.

• In Q2 2026, Change in Account Payables rose 390.52% year-over-year to $44766.0; the TTM figure through Jun 2026 stood at $95988.0 (up 274.77% YoY), while the FY2025 annual figure was $51267.0, down 16.25% from the prior year.
• Change in Account Payables came in at $44766.0 for Q2 2026 at Nutra Pharma, up from -$8723.0 in the prior quarter.
• In the past five years, Change in Account Payables ranged from a high of $81579.0 in Q4 2025 to a low of -$70469.0 in Q2 2022.
• Average Change in Account Payables over 5 years is $13283.9, with a median of $9747.5 recorded in 2023.
• Year-over-year, Change in Account Payables slumped 1114.23% in 2022 and soared 540.37% in 2025.
• Over 5 years, Change in Account Payables stood at $14611.0 in 2022, then decreased by 28.28% to $10479.0 in 2023, then tumbled by 276.78% to -$18525.0 in 2024, then soared by 540.37% to $81579.0 in 2025, then tumbled by 45.13% to $44766.0 in 2026.
• Per Business Quant data, the three most recent Change in Account Payables figures were $44766.0 in Q2 2026, -$8723.0 in Q1 2026, and $81579.0 in Q4 2025.